Back to mobile site

Ligand Pharma (LGND) Tops Q2 EPS by 13c

July 30, 2019 8:04 AM EDT Send to a Friend
Ligand Pharma (NASDAQ: LGND) reported Q2 EPS of $0.68 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login